Table 1.
Characteristics | N (%), median (range) |
---|---|
Age (34 available) (years) | 61.5 ± 17.9 (19-85) |
≥65 | 18 (52.9) |
<65 | 16 (47.1) |
Gender (39 available) | |
Male | 31 (79.5) |
Female | 8 (20.5) |
Race (39 available) | |
Caucasian | 32 (82.1) |
Asian | 7 (17.9) |
Histology (39 available) | |
Pure | 22 (56.4) |
Mixed | 17 (43.6) |
Tumor size (cm) (16 available) | 4.11 ± 1.76 (1.0–9.1) |
TNM stage (30 available) | |
I–II | 9 (30.0) |
III–IV | 21 (70.0) |
Pathologic stage (30 available) | |
T1–2 | 10 (33.3) |
T3–4 | 20 (66.7) |
Pathologic node status (22 available) | |
N0 | 14 (66.7) |
N+ | 7 (33.3) |
Distant metastasis at diagnosis (24 available) | |
M0 | 18 (75.0) |
M+ | 6 (25.0) |
Surgery (38 available) | |
RC | 27 (71.1) |
PC | 4 (10.5) |
TURBT | 7 (18.4) |
Adjuvant chemotherapy (39 available) | |
Yes | 24 (61.5) |
No | 15 (38.5) |
Radiotherapy (39 available) | |
Yes | 8 (20.5) |
No | 31 (79.5) |
RC, radical cystectomy; PC, partial cystectomy; TURBT, transurethral resection of bladder tumor.